Physician profile
Michelle Springstead
NPI 1508936055
$6,450.92
in general payments reported to CMS, 2019-2025
28 companies · $2,244 in 2025
The $2,244 reported for 2025 was more than what 95% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $27.33 · 2022: $46.58 · 2023: $856 · 2024: $3,277 · 2025: $2,244.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,873 · Travel and Lodging: $1,504.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,873.31 |
| Travel and Lodging | $1,503.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $2,727.15 | 2023-2025 | Watchman Access System, Watchman Flx, Varithena Administration Pack |
| Pfizer INC. | $484.47 | 2024-2025 | |
| Novartis Pharmaceuticals Corporation | $401.35 | 2022-2025 | |
| Lexicon Pharmaceuticals, INC. | $377.47 | 2023-2024 | Inpefa |
| Merck Sharp & Dohme LLC | $344.92 | 2023-2025 | Verquvo |
| Astrazeneca Pharmaceuticals LP | $340.97 | 2021-2024 | Brilinta, Farxiga |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $206.97 | 2023-2024 | Lifevest |
| Impulse Dynamics (USA) INC. | $176.31 | 2025 | Optimizer |
| Edwards Lifesciences Corporation | $153.50 | 2024 | Sapien 3 Ultra Resilia |
| E.R. Squibb & Sons, L.L.C. | $147.37 | 2024-2025 | Camzyos, Eliquis |
| Biosense Webster, INC. | $145.77 | 2024 | Carto 3 |
| Amgen INC. | $132.02 | 2022-2025 | Repatha, Repatha |
| Medtronic, INC. | $126.67 | 2024 | Linq II |
| Alnylam Pharmaceuticals INC. | $105.81 | 2024 | Onpattro |
| Janssen Pharmaceuticals, INC | $102.58 | 2023-2024 | Xarelto |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kestra Medical Technology Services, INC. | $84.42 | 2023-2024 | Assure Wcd |
| Bridgebio Pharma, INC. | $75.25 | 2025 | Attruby |
| Esperion Therapeutics, INC. | $67.11 | 2024-2025 | Nexletol |
| Bayer Healthcare Pharmaceuticals INC. | $58.69 | 2023-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $35.19 | 2023 | Jardiance |
| Regeneron Healthcare Solutions, INC. | $32.03 | 2024 | Evkeeza |
| Kiniksa Pharmaceuticals International, Plc | $21.31 | 2024 | Arcalyst |
| Inari Medical, INC. | $20.94 | 2023 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Cvrx, INC. | $20.57 | 2024 | Barostim Neo System |
| Scpharmaceuticals INC. | $17.35 | 2023 | |
| Lilly USA, LLC | $15.57 | 2025 | Mounjaro, Zepbound |
| Innovation Technologies INC | $15.21 | 2025 | Irrisept |
| Irhythm Technologies, INC. | $13.95 | 2023 | Zio Xt Patch |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michelle Springstead listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.